Intravenous Infusions is trading at GHS 0.55, up 10.00%, rebounding after recent declines.
- The share price rose from GHS 0.50 on August 17, 2026, to GHS 0.55 on August 18, 2026.
- No clear company-specific announcement or new catalyst explaining the August 20, 2026 movement was identified.
- Broader healthcare strength offers limited supporting context, while Ghana’s market was largely unchanged on August 19, 2026.